A comparison of the incidence and understanding of altitude illness between porters and trekkers in the Solu Khumbu Region of Nepal
- PMID: 21962045
- DOI: 10.1016/j.wem.2011.06.001
A comparison of the incidence and understanding of altitude illness between porters and trekkers in the Solu Khumbu Region of Nepal
Abstract
Objective: Altitude illness can occur in anyone who ascends to high altitude. Better understanding of altitude illness is associated with a lower incidence of acute mountain sickness (AMS). The purpose of this study is to compare, for the first time, the incidence and understanding of altitude illness between foreign trekkers and indigenous porters in Nepal.
Methods: Interviews and questionnaires were completed at the International Porter Protection Group Rescue Post at Machermo (4470 m). Participants completed the Lake Louise acute mountain sickness self-assessment questionnaire. They were also asked about their actions in response to high altitude illness scenarios as well as their perception of the vulnerability of porters vs trekkers to altitude illness. Ascent profile, age, gender, ethnic origin, and altitude of home residence were also obtained.
Results: Trekkers (n=131) had a significantly higher incidence of AMS (21% vs 8%) than porters (n=92; P < .02). Lowland porters (whose home villages were below 3050 m, n=61) had a numerically higher, though not significantly different, incidence of AMS (10% vs 3%) compared to highland porters (n=31). The majority of trekkers and porters recognized the symptoms of altitude illness and the most appropriate action to be taken. Despite the lower incidence of AMS in porters, around half felt that they were at greater risk than trekkers.
Conclusions: Porters had a lower incidence of AMS, which may be attributable to repeated ascents through the trekking season, or differences in reporting symptoms. Both trekkers and porters demonstrated appropriate knowledge of actions to be taken in response to altitude illness.
Copyright © 2011 Wilderness Medical Society. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Understanding of Altitude Illness and Use of Pharmacotherapy Among Trekkers and Porters in the Annapurna Region of Nepal.High Alt Med Biol. 2015 Sep;16(3):236-43. doi: 10.1089/ham.2015.0044. Epub 2015 Aug 5. High Alt Med Biol. 2015. PMID: 26244262
-
Acute mountain sickness and ascent rates in trekkers above 2500 m in the Nepali Himalaya.Aviat Space Environ Med. 2006 Jul;77(7):742-4. Aviat Space Environ Med. 2006. PMID: 16856361
-
Clinical features of patients with severe altitude illness in Nepal.J Travel Med. 2008 Sep-Oct;15(5):315-22. doi: 10.1111/j.1708-8305.2008.00229.x. J Travel Med. 2008. PMID: 19006504
-
A Review of Medical Problems in Himalayan Porters.High Alt Med Biol. 2020 Jun;21(2):109-113. doi: 10.1089/ham.2020.0004. Epub 2020 Apr 20. High Alt Med Biol. 2020. PMID: 32311284 Review.
-
Fatalities in high altitude mountaineering: a review of quantitative risk estimates.High Alt Med Biol. 2013 Dec;14(4):346-59. doi: 10.1089/ham.2013.1046. High Alt Med Biol. 2013. PMID: 24377342 Review.
Cited by
-
Effects of dietary nitrate on respiratory physiology at high altitude - Results from the Xtreme Alps study.Nitric Oxide. 2017 Dec 1;71:57-68. doi: 10.1016/j.niox.2017.10.005. Epub 2017 Oct 16. Nitric Oxide. 2017. PMID: 29042272 Free PMC article.
-
Differences Between the "Chinese AMS Score" and the Lake Louise Score in the Diagnosis of Acute Mountain Sickness.Medicine (Baltimore). 2016 May;95(21):e3512. doi: 10.1097/MD.0000000000003512. Medicine (Baltimore). 2016. PMID: 27227918 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources